Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke

Babak B. Navi(Cornell University), Christopher Streib(University of Minnesota), David Tirschwell(University of Washington), Giovanni Bianco(Laboratory for Biomedical Neurosciences), Mitchell S.V. Elkind(Columbia University), Mary Cushman(University of Vermont), W. T. Longstreth(University of Washington), Gianluca Costamagna(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Richard A. Kronmal(University of Washington), Richard M. Zweifler(Ochsner Health System), Patrik Michel(University of Lausanne), Hooman Kamel(Cornell University), Morin Beyeler(University of Bern), Carlo W. Cereda(Laboratory for Biomedical Neurosciences), Benjamin Miller(University of Minnesota), Cenai Zhang(Weill Cornell Medicine), Joseph P. Broderick(University of Cincinnati), Jordan Elm(Medical University of South Carolina), David J. Gladstone(Sunnybrook Health Science Centre), Joseph Tarsia(Ochsner Health System), Scott E. Kasner(University of Pennsylvania)
JAMA Neurology
August 12, 2024
10.1001/jamaneurol.2024.2404
Cited by 21

Related Papers

Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
|Circulation|2020|9.4k
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
|Circulation|2019|9.1k
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
|Stroke|2019|7.2k
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Heart Disease and Stroke Statistics—2021 Update
|Circulation|2021|5.7k